{"disease":{"id":"bipolar-depression","name":"Bipolar depression","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:31:21.551Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":0,"pipeline_drug_count":1,"trial_count":2},"drugs":{"marketed":[{"drug_id":"fluoxetine","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prozac","generic_name":"fluoxetine","company_name":"Eli Lilly and Company","drug_phase":"marketed","molecular_target":"Serotonin reuptake transporter","drug_class":"Selective Serotonin Reuptake Inhibitor (SSRI)","quality_score":81,"revenue":"1000.0","mechanism":"Fluoxetine inhibits CNS neuronal uptake of serotonin, though exact mechanism unknown."},{"drug_id":"olanzapine","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zyprexa","generic_name":"olanzapine","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"Atypical Antipsychotic [EPC]","quality_score":10,"revenue":"300","mechanism":null},{"drug_id":"quetiapine","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Seroquel","generic_name":"quetiapine","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"prozac","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Prozac","company_name":"RenJi Hospital","drug_phase":"marketed","molecular_target":"Equilibrative nucleoside transporter 4, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"lurasidone","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Latuda","generic_name":"LURASIDONE","company_name":"Sunovion Pharms Inc","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Atypical Antipsychotic","quality_score":80,"revenue":null,"mechanism":"Latuda works by blocking the action of serotonin at the 5-hydroxytryptamine receptor 2A, which helps to regulate mood and reduce symptoms of psychosis."},{"drug_id":"doxepin","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zonalon","generic_name":"DOXEPIN","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Tricyclic Antidepressant","quality_score":80,"revenue":null,"mechanism":"Zonalon works by blocking histamine H1 receptors in the brain, which helps to reduce anxiety and itching, and improve mood."},{"drug_id":"seroquel","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Seroquel","company_name":"University of Pittsburgh","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"quetiapin","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Quetiapin","company_name":"Sykehuset Innlandet HF","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"zyprexa","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zyprexa","company_name":"Washington University School of Medicine","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lurasidone","indication_name":"Bipolar Depression (Adjunctive Therapy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Latuda","generic_name":"LURASIDONE","company_name":"Sunovion Pharms Inc","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Atypical Antipsychotic","quality_score":80,"revenue":null,"mechanism":"Latuda works by blocking the action of serotonin at the 5-hydroxytryptamine receptor 2A, which helps to regulate mood and reduce symptoms of psychosis."},{"drug_id":"lurasidone","indication_name":"Bipolar Depression (Monotherapy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Latuda","generic_name":"LURASIDONE","company_name":"Sunovion Pharms Inc","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Atypical Antipsychotic","quality_score":80,"revenue":null,"mechanism":"Latuda works by blocking the action of serotonin at the 5-hydroxytryptamine receptor 2A, which helps to regulate mood and reduce symptoms of psychosis."}],"pipeline":[{"drug_id":"scopolamine","indication_name":"Bipolar depression","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SCOPOLAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptors","drug_class":"Anticholinergic [EPC]","quality_score":55,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":11,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT06818227","title":"MonPsy&Moi: A Digital Platform for Collecting Patient-Reported Experience and Outcome Measures in Psychiatry","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":23660,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT00024635","title":"Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers","phase":"","overall_status":"RECRUITING","enrollment_count":16000,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT06433635","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2726,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT00001260","title":"Brain Tissue Collection for Neuropathological Studies","phase":"","overall_status":"TERMINATED","enrollment_count":2161,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT07189689","title":"Mental Health Mission Mood Disorder Cohort Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT07212075","title":"Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups","phase":"","overall_status":"RECRUITING","enrollment_count":1809,"lead_sponsor_name":"Forschungsinstitut der Diabetes Akademie Mergentheim","has_results":false},{"nct_id":"NCT03656770","title":"Measuring Beliefs and Norms About Persons With Mental Illness","phase":"NA","overall_status":"COMPLETED","enrollment_count":1782,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT05669703","title":"NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder","phase":"","overall_status":"RECRUITING","enrollment_count":1260,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT05603104","title":"Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1254,"lead_sponsor_name":"Dr. Inge Winter","has_results":false},{"nct_id":"NCT03573297","title":"A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":901,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT05801562","title":"Development of a Software Tool, Using Artificial Intelligence, That Integrates Clinical, Biological, Genetic and Imaging Data to Predict Diagnosis and Outcome of Depressed Patients in Order to Enhance Prognosis and Limiting Healthcare Costs.","phase":"","overall_status":"UNKNOWN","enrollment_count":730,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT01914393","title":"Pediatric Open-Label Extension Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":702,"lead_sponsor_name":"Sumitomo Pharma America, Inc.","has_results":true},{"nct_id":"NCT07031817","title":"Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder","phase":"NA","overall_status":"RECRUITING","enrollment_count":623,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT07033923","title":"Neuro-computational Study of Thymic Fluctuations in Mood Disorders","phase":"NA","overall_status":"RECRUITING","enrollment_count":588,"lead_sponsor_name":"Centre Hospitalier St Anne","has_results":false},{"nct_id":"NCT02600494","title":"Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":554,"lead_sponsor_name":"Intra-Cellular Therapies, Inc.","has_results":true},{"nct_id":"NCT02600507","title":"Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":529,"lead_sponsor_name":"Intra-Cellular Therapies, Inc.","has_results":true},{"nct_id":"NCT01986101","title":"A Phase III Study of SM-13496 in Patients With Bipolar I Depression.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":525,"lead_sponsor_name":"Sumitomo Pharma Co., Ltd.","has_results":true},{"nct_id":"NCT02670538","title":"Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":493,"lead_sponsor_name":"Forest Laboratories","has_results":true},{"nct_id":"NCT04285515","title":"Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":488,"lead_sponsor_name":"Intra-Cellular Therapies, Inc.","has_results":true},{"nct_id":"NCT02670551","title":"Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":488,"lead_sponsor_name":"Forest Laboratories","has_results":true},{"nct_id":"NCT05973786","title":"The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":418,"lead_sponsor_name":"Dr. Inge Winter","has_results":false},{"nct_id":"NCT06417437","title":"Non-invasive BCI and Application Verification for Depressed People","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT04664374","title":"Characterizing MyMood Patterns of Use","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT05965232","title":"FIbrosis and Steatosis in Patients With Psychiatric Illness","phase":"","overall_status":"COMPLETED","enrollment_count":385,"lead_sponsor_name":"Centre Hospitalier Esquirol","has_results":false},{"nct_id":"NCT03249376","title":"Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":381,"lead_sponsor_name":"Intra-Cellular Therapies, Inc.","has_results":true},{"nct_id":"NCT01980147","title":"Skills for Wellness","phase":"NA","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Nova Scotia Health Authority","has_results":false},{"nct_id":"NCT03543410","title":"A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":344,"lead_sponsor_name":"Sumitomo Pharma America, Inc.","has_results":true},{"nct_id":"NCT05698589","title":"COMpassion for Psychiatric Disorders And Self-Stigma","phase":"NA","overall_status":"RECRUITING","enrollment_count":336,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT06369805","title":"EVALUATION OF BLOOD BIOMARKER-BASED DIAGNOSTIC AID IN OUTPATIENTS SUFFERING FROM DEPRESSION","phase":"","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Les Toises - Psychiatry and Psychotherapy Center","has_results":false},{"nct_id":"NCT03615794","title":"A Study of Pregnant and Postpartum Women With and Without Mood Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT02150577","title":"Implementation Trial of Evidence Based Practices for Mood Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":291,"lead_sponsor_name":"University of Arkansas","has_results":false},{"nct_id":"NCT06662526","title":"Lithium for Prevention of Cognitive Declining in Mood Illnesses","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":250,"lead_sponsor_name":"University of Chile","has_results":false},{"nct_id":"NCT00852202","title":"Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"Forest Laboratories","has_results":true},{"nct_id":"NCT00026832","title":"Examination of Brain Serotonin Receptors in Patients With Mood Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":214,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT05065489","title":"Resting State Electroencephalogram for Psychotic Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":201,"lead_sponsor_name":"Central South University","has_results":false},{"nct_id":"NCT03862209","title":"Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health (RECOVER-E) Croatia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Klinički Bolnički Centar Zagreb","has_results":false},{"nct_id":"NCT03217110","title":"Cerebellar Stimulation and Cognitive Control","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Krystal Parker, PhD","has_results":false},{"nct_id":"NCT06369792","title":"PROSPECTIVE EVALUATION OF BLOOD BIOMARKERS AS AN AID TO DIAGNOSTIC AND TREATMENT IN DRUG-NAIVE PATIENTS WITH DEPRESSION","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Les Toises - Psychiatry and Psychotherapy Center","has_results":false},{"nct_id":"NCT04471454","title":"Verification of the Reliability and Validity of THINC-it Tool in Bipolar Depression","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT00055575","title":"Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":197,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT06121206","title":"Effects of Altitude-like Cognition Training on Neuroplasticity and Cognitive Functions","phase":"NA","overall_status":"COMPLETED","enrollment_count":190,"lead_sponsor_name":"Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital","has_results":false},{"nct_id":"NCT03922425","title":"Community-based Mental Health Care for People With Severe and Enduring Mental III Health","phase":"NA","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"The National Center for Public Health and Analyzes, Bulgaria","has_results":false},{"nct_id":"NCT05703412","title":"Effectiveness of mHealth Post-discharge Intervention for Patients With Severe Mental Illness","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":180,"lead_sponsor_name":"Butler Hospital","has_results":false},{"nct_id":"NCT07404085","title":"Epigenetic Enhancement of Cognitive Training in Aging Mood Disorder Populations","phase":"NA","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital","has_results":false},{"nct_id":"NCT03837340","title":"Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health","phase":"NA","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Special Psychiatric Hospital Kotor","has_results":false},{"nct_id":"NCT03892473","title":"Community-based Mental Health Care for People With Severe and Enduring Mental III Health ( RECOVER-E )","phase":"NA","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"University of Skopje","has_results":false},{"nct_id":"NCT03396601","title":"NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"NeuroRx, Inc.","has_results":false},{"nct_id":"NCT04399070","title":"The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Yan Qiu","has_results":false},{"nct_id":"NCT04004416","title":"Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT01542229","title":"PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)","phase":"NA","overall_status":"COMPLETED","enrollment_count":134,"lead_sponsor_name":"VA Office of Research and Development","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}